Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank83
3Y CAGR+80.5%
5Y CAGR+221.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+80.5%/yr
Annual compound
5Y CAGR
+221.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
342.2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.61M | -5.6% |
| 2024 | $25.02M | +76.3% |
| 2023 | $14.19M | +253.3% |
| 2022 | $4.02M | +899.5% |
| 2021 | $402000.00 | +482.6% |
| 2020 | $69000.00 | -68.5% |
| 2019 | $219000.00 | - |